Table of Content

1 Introduction 5
1.1 Industry Definition and Research Scope 5
1.1.1 Industry Definition 5
1.1.2 Research Scope 6
1.2 Research Methodology 9
1.2.1 Overview of Market Research Methodology 9
1.2.2 Market Assumption 10
1.2.3 Secondary Data 10
1.2.4 Primary Data 10
1.2.5 Data Filtration and Model Design 11
1.2.6 Market Size/Share Estimation 12
1.2.7 Research Limitations 13
1.3 Executive Summary 14

2 Market Overview and Dynamics 16
2.1 Market Size and Forecast 16
2.1.1 Impact of COVID-19 on World Economy 17
2.1.2 Impact of COVID-19 on the Market 19
2.2 Major Growth Drivers 21
2.3 Market Restraints and Challenges 24
2.4 Emerging Opportunities and Market Trends 27
2.5 Porter’s Fiver Forces Analysis 31

3 Segmentation of North America Market by Type 35
3.1 Market Overview by Type 35
3.2 Monoclonal Antibodies 37
3.3 Polyclonal Antibodies 38
3.4 Other Types 39

4 Segmentation of North America Market by Application 40
4.1 Market Overview by Application 40
4.2 Oncology Diagnosis 42
4.3 Hepatitis Diagnosis 43
4.4 Infectious Disease Diagnosis 44
4.5 Dengue Diagnostics 45
4.6 Tuberculosis Diagnostics 46
4.7 HIV Diagnostics 47
4.8 Other Applications 48

5 Segmentation of North America Market by End User 49
5.1 Market Overview by End User 49
5.2 Hospitals & Clinics 51
5.3 Diagnostic Laboratories 52
5.4 Other End Users 53

6 North America Market 2020-2027 by Country 54
6.1 Overview of North America Market 54
6.2 U.S. 57
6.3 Canada 60
6.4 Mexico 62

7 Competitive Landscape 64
7.1 Overview of Key Vendors 64
7.2 New Product Launch, Partnership, Investment, and M&A 67
7.3 Company Profiles 68
Abbott Laboratories 68
Abcam plc 70
Agilent Technologies, Inc. 71
Aytu BioScience, Inc. 72
Becton, Dickinson and Company 73
Bio-Rad Laboratories, Inc. 74
Boehringer Ingelheim International GmbH 75
Creative Diagnostics 76
Enzo Life Sciences, Inc. 77
F. Hoffmann-La Roche AG 78
Merck KGaA 79
Polymun Scientific Immunbiologische Forschung GmbH 80
Sanofi S.A. 81
Sartorius AG 82
Thermo Fisher Scientific Inc. 83
RELATED REPORTS 84



List of Figures

Figure 1. Research Method Flow Chart 9
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 12
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027 14
Figure 4. North America Diagnostic Specialty Antibodies Market, 2017-2027, $ mn 16
Figure 5. Impact of COVID-19 on Business 19
Figure 6. Primary Drivers and Impact Factors of North America Diagnostic Specialty Antibodies Market 21
Figure 7. Primary Restraints and Impact Factors of North America Diagnostic Specialty Antibodies Market 24
Figure 8. Investment Opportunity Analysis 28
Figure 9. Porter’s Fiver Forces Analysis of North America Diagnostic Specialty Antibodies Market 31
Figure 10. Breakdown of North America Diagnostic Specialty Antibodies Market by Type, 2020-2027, % of Revenue 35
Figure 11. Contribution to North America 2021-2027 Cumulative Revenue by Type, Value ($ mn) and Share (%) 36
Figure 12. North America Diagnostic Specialty Antibodies Market: Monoclonal Antibodies, 2017-2027, $ mn 37
Figure 13. North America Diagnostic Specialty Antibodies Market: Polyclonal Antibodies, 2017-2027, $ mn 38
Figure 14. North America Diagnostic Specialty Antibodies Market: Other Types, 2017-2027, $ mn 39
Figure 15. Breakdown of North America Diagnostic Specialty Antibodies Market by Application, 2020-2027, % of Revenue 40
Figure 16. Contribution to North America 2021-2027 Cumulative Revenue by Application, Value ($ mn) and Share (%) 41
Figure 17. North America Diagnostic Specialty Antibodies Market: Oncology Diagnosis, 2017-2027, $ mn 42
Figure 18. North America Diagnostic Specialty Antibodies Market: Hepatitis Diagnosis, 2017-2027, $ mn 43
Figure 19. North America Diagnostic Specialty Antibodies Market: Infectious Disease Diagnosis, 2017-2027, $ mn 44
Figure 20. North America Diagnostic Specialty Antibodies Market: Dengue Diagnostics, 2017-2027, $ mn 45
Figure 21. North America Diagnostic Specialty Antibodies Market: Tuberculosis Diagnostics, 2017-2027, $ mn 46
Figure 22. North America Diagnostic Specialty Antibodies Market: HIV Diagnostics, 2017-2027, $ mn 47
Figure 23. North America Diagnostic Specialty Antibodies Market: Other Applications, 2017-2027, $ mn 48
Figure 24. Breakdown of North America Diagnostic Specialty Antibodies Market by End User, 2020-2027, % of Revenue 49
Figure 25. Contribution to North America 2021-2027 Cumulative Revenue by End User, Value ($ mn) and Share (%) 50
Figure 26. North America Diagnostic Specialty Antibodies Market: Hospitals & Clinics, 2017-2027, $ mn 51
Figure 27. North America Diagnostic Specialty Antibodies Market: Diagnostic Laboratories, 2017-2027, $ mn 52
Figure 28. North America Diagnostic Specialty Antibodies Market: Other End Users, 2017-2027, $ mn 53
Figure 29. Breakdown of North America Diagnostic Specialty Antibodies Market by Country, 2020 and 2027, % of Revenue 55
Figure 30. Contribution to North America 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%) 56
Figure 31. U.S. Diagnostic Specialty Antibodies Market, 2017-2027, $ mn 58
Figure 32. Canada Diagnostic Specialty Antibodies Market, 2017-2027, $ mn 60
Figure 33. Diagnostic Specialty Antibodies Market in Mexico, 2017-2027, $ mn 62
Figure 34. Growth Stage of North America Diagnostic Specialty Antibodies Industry over the Forecast Period 64

List of Tables

Table 1. Snapshot of North America Diagnostic Specialty Antibodies Market in Balanced Perspective, 2020-2027 15
Table 2. Growth Rate of World GDP, 2020-2022 18
Table 3. Main Product Trends and Market Opportunities in North America Diagnostic Specialty Antibodies Market 27
Table 4. North America Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn 35
Table 5. North America Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn 40
Table 6. North America Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn 49
Table 7. North America Diagnostic Specialty Antibodies Market by Country, 2017-2027, $ mn 55
Table 8. U.S. Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn 59
Table 9. U.S. Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn 59
Table 10. U.S. Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn 59
Table 11. Canada Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn 61
Table 12. Canada Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn 61
Table 13. Canada Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn 61
Table 14. Mexico Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn 63
Table 15. Mexico Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn 63
Table 16. Mexico Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn 63
Table 17. Abbott Laboratories: Company Snapshot 68
Table 18. Abbott Laboratories: Business Segmentation 68
Table 19. Abbott Laboratories: Product Portfolio 69
Table 20. Abbott Laboratories: Revenue, 2017-2019, $ mn 69